DL

Dalin Li

CC Cedars Sinai Medical Center: 9 patents #32 of 524Top 7%
PB Prometheus Biosciences: 3 patents #6 of 30Top 20%
📍 Los Angeles, CA: #1,398 of 12,377 inventorsTop 15%
🗺 California: #66,801 of 386,348 inventorsTop 20%
Overall (All Time): #531,228 of 4,157,543Top 15%
9
Patents All Time

Issued Patents All Time

Showing 1–9 of 9 patents

Patent #TitleCo-InventorsDate
12391752 Methods of enriching or amplifying nucleic acids in a sample from a patient with inflammatory bowel disease Laurens Kruidenier, Mahyar SABRIPOUR, Janine Bilsborough, Dermot P. McGovern 2025-08-19
12215147 Methods of selecting, based on polymorphisms, an inflammatory bowel disease subject for treatment with an anti-TL1A antibody Laurens Kruidenier, Mahyar SABRIPOUR, Janine Bilsborough, Dermot P. McGovern 2025-02-04
12018086 Kit comprising contiguous nucleobases, including position 76, of RS5745994 Dermot P. McGovern, Stephan R. Targan 2024-06-25
11549146 Diagnosis of inflammatory bowel disease based on genes Dermot P. McGovern 2023-01-10
11434296 Mitigation and reversal of intestinal fibrosis and inflammation by inhibition of TL1A function David Q. Shih, Stephan R. Targan, Janine Bilsborough 2022-09-06
11180565 Method of enriching a target nucleic acid at a TNFRSF1B gene locus in a sample from a subject with inflammatory bowel disease Dermot P. McGovern, Stephan R. Targan 2021-11-23
11136386 Methods of treating Crohn's disease or ulcerative colitis by administering inhibitors of tumor necrosis factor-like cytokine 1A (TL1A) Laurens Kruidenier, Mahyar SABRIPOUR, Janine Bilsborough, Dermot P. McGovern 2021-10-05
10633449 Treatment and reversal of fibrosis and inflammation by inhibition of the TL1A-DR3 signaling pathway David Q. Shih, Stephan R. Targan, Janine Bilsborough 2020-04-28
10626180 Methods of treating and predicting non-response to anti-TNF treatment in subjects with inflammatory bowel disease Dermot P. McGovern, Stephan R. Targan 2020-04-21